290 related articles for article (PubMed ID: 24089324)
1. Poly (ADP-ribose) polymerase-1 is a key mediator of liver inflammation and fibrosis.
Mukhopadhyay P; Rajesh M; Cao Z; Horváth B; Park O; Wang H; Erdelyi K; Holovac E; Wang Y; Liaudet L; Hamdaoui N; Lafdil F; Haskó G; Szabo C; Boulares AH; Gao B; Pacher P
Hepatology; 2014 May; 59(5):1998-2009. PubMed ID: 24089324
[TBL] [Abstract][Full Text] [Related]
2. PARP inhibition protects against alcoholic and non-alcoholic steatohepatitis.
Mukhopadhyay P; Horváth B; Rajesh M; Varga ZV; Gariani K; Ryu D; Cao Z; Holovac E; Park O; Zhou Z; Xu MJ; Wang W; Godlewski G; Paloczi J; Nemeth BT; Persidsky Y; Liaudet L; Haskó G; Bai P; Boulares AH; Auwerx J; Gao B; Pacher P
J Hepatol; 2017 Mar; 66(3):589-600. PubMed ID: 27984176
[TBL] [Abstract][Full Text] [Related]
3. Poly(ADP-ribose) polymerase-1 inhibition increases expression of heat shock proteins and attenuates heat stroke-induced liver injury.
Mota RA; Hernández-Espinosa D; Galbis-Martinez L; Ordoñez A; Miñano A; Parrilla P; Vicente V; Corral J; Yélamos J
Crit Care Med; 2008 Feb; 36(2):526-34. PubMed ID: 18091544
[TBL] [Abstract][Full Text] [Related]
4. Poly(ADP-ribose) Polymerase (PARP) and PARP Inhibitors: Mechanisms of Action and Role in Cardiovascular Disorders.
Henning RJ; Bourgeois M; Harbison RD
Cardiovasc Toxicol; 2018 Dec; 18(6):493-506. PubMed ID: 29968072
[TBL] [Abstract][Full Text] [Related]
5. Puerarin protects against CCl4-induced liver fibrosis in mice: possible role of PARP-1 inhibition.
Wang S; Shi XL; Feng M; Wang X; Zhang ZH; Zhao X; Han B; Ma HC; Dai B; Ding YT
Int Immunopharmacol; 2016 Sep; 38():238-45. PubMed ID: 27318789
[TBL] [Abstract][Full Text] [Related]
6. Poly(ADP-Ribose) Polymerase 1 Promotes Inflammation and Fibrosis in a Mouse Model of Chronic Pancreatitis.
El-Hamoly T; Hajnády Z; Nagy-Pénzes M; Bakondi E; Regdon Z; Demény MA; Kovács K; Hegedűs C; Abd El-Rahman SS; Szabó É; Maléth J; Hegyi P; Virág L
Int J Mol Sci; 2021 Mar; 22(7):. PubMed ID: 33808340
[TBL] [Abstract][Full Text] [Related]
7. Poly(ADP-ribose) polymerase-1 is a key mediator of cisplatin-induced kidney inflammation and injury.
Mukhopadhyay P; Horváth B; Kechrid M; Tanchian G; Rajesh M; Naura AS; Boulares AH; Pacher P
Free Radic Biol Med; 2011 Nov; 51(9):1774-88. PubMed ID: 21884784
[TBL] [Abstract][Full Text] [Related]
8. Dihydrokaempferol attenuates CCl
Huang H; Wei S; Wu X; Zhang M; Zhou B; Huang D; Dong W
Toxicol Appl Pharmacol; 2023 Apr; 464():116438. PubMed ID: 36841340
[TBL] [Abstract][Full Text] [Related]
9. Inhibiting poly ADP-ribosylation increases fatty acid oxidation and protects against fatty liver disease.
Gariani K; Ryu D; Menzies KJ; Yi HS; Stein S; Zhang H; Perino A; Lemos V; Katsyuba E; Jha P; Vijgen S; Rubbia-Brandt L; Kim YK; Kim JT; Kim KS; Shong M; Schoonjans K; Auwerx J
J Hepatol; 2017 Jan; 66(1):132-141. PubMed ID: 27663419
[TBL] [Abstract][Full Text] [Related]
10. Poly(ADP-ribose) polymerase-1 is a determining factor in Crm1-mediated nuclear export and retention of p65 NF-kappa B upon TLR4 stimulation.
Zerfaoui M; Errami Y; Naura AS; Suzuki Y; Kim H; Ju J; Liu T; Hans CP; Kim JG; Abd Elmageed ZY; Koochekpour S; Catling A; Boulares AH
J Immunol; 2010 Aug; 185(3):1894-902. PubMed ID: 20610652
[TBL] [Abstract][Full Text] [Related]
11. A novel and potent poly(ADP-ribose) polymerase-1 inhibitor, FR247304 (5-chloro-2-[3-(4-phenyl-3,6-dihydro-1(2H)-pyridinyl)propyl]-4(3H)-quinazolinone), attenuates neuronal damage in in vitro and in vivo models of cerebral ischemia.
Iwashita A; Tojo N; Matsuura S; Yamazaki S; Kamijo K; Ishida J; Yamamoto H; Hattori K; Matsuoka N; Mutoh S
J Pharmacol Exp Ther; 2004 Aug; 310(2):425-36. PubMed ID: 15075382
[TBL] [Abstract][Full Text] [Related]
12. Regulation of myofibroblast differentiation by poly(ADP-ribose) polymerase 1.
Hu B; Wu Z; Hergert P; Henke CA; Bitterman PB; Phan SH
Am J Pathol; 2013 Jan; 182(1):71-83. PubMed ID: 23260200
[TBL] [Abstract][Full Text] [Related]
13. Pathophysiological role of poly(ADP-ribose) polymerase (PARP) activation during acetaminophen-induced liver cell necrosis in mice.
Cover C; Fickert P; Knight TR; Fuchsbichler A; Farhood A; Trauner M; Jaeschke H
Toxicol Sci; 2005 Mar; 84(1):201-8. PubMed ID: 15601672
[TBL] [Abstract][Full Text] [Related]
14. Poly (ADP-ribose) polymerase: An Overview of Mechanistic Approaches and Therapeutic Opportunities in the Management of Stroke.
Tiwari P; Khan H; Singh TG; Grewal AK
Neurochem Res; 2022 Jul; 47(7):1830-1852. PubMed ID: 35437712
[TBL] [Abstract][Full Text] [Related]
15. Poly(ADP-ribose) polymerase 1 inhibition protects cardiomyocytes from inflammation and apoptosis in diabetic cardiomyopathy.
Qin WD; Liu GL; Wang J; Wang H; Zhang JN; Zhang F; Ma Y; Ji XY; Li C; Zhang MX
Oncotarget; 2016 Jun; 7(24):35618-35631. PubMed ID: 27027354
[TBL] [Abstract][Full Text] [Related]
16. Inhibition of poly(ADP-ribose) polymerase-1 attenuates the toxicity of carbon tetrachloride.
Banasik M; Stedeford T; Strosznajder RP; Takehashi M; Tanaka S; Ueda K
J Enzyme Inhib Med Chem; 2011 Dec; 26(6):883-9. PubMed ID: 21395487
[TBL] [Abstract][Full Text] [Related]
17. Inhibition of Poly(ADP-Ribose) Polymerase-1 Protects Chronic Alcoholic Liver Injury.
Zhang Y; Wang C; Tian Y; Zhang F; Xu W; Li X; Shu Z; Wang Y; Huang K; Huang D
Am J Pathol; 2016 Dec; 186(12):3117-3130. PubMed ID: 27746183
[TBL] [Abstract][Full Text] [Related]
18. Poly(ADP-ribose) polymerase-1 inhibition prevents eosinophil recruitment by modulating Th2 cytokines in a murine model of allergic airway inflammation: a potential specific effect on IL-5.
Oumouna M; Datta R; Oumouna-Benachour K; Suzuki Y; Hans C; Matthews K; Fallon K; Boulares H
J Immunol; 2006 Nov; 177(9):6489-96. PubMed ID: 17056581
[TBL] [Abstract][Full Text] [Related]
19. Inhibition of poly(ADP-ribose) polymerase attenuates the severity of acute pancreatitis and associated lung injury.
Mota RA; Sánchez-Bueno F; Saenz L; Hernández-Espinosa D; Jimeno J; Tornel PL; Martínez-Torrano A; Ramírez P; Parrilla P; Yélamos J
Lab Invest; 2005 Oct; 85(10):1250-62. PubMed ID: 16127429
[TBL] [Abstract][Full Text] [Related]
20. Role of poly(ADP-ribose) polymerase 1 (PARP-1) in cardiovascular diseases: the therapeutic potential of PARP inhibitors.
Pacher P; Szabó C
Cardiovasc Drug Rev; 2007; 25(3):235-60. PubMed ID: 17919258
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
